King A., et al. Human uterine lymphocytes. Hum. Reprod. Update, 1998; 4:480–485.
King A., Gardner L., Loke Y. W. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum. Reprod., 1996; 11:1079–1082.
King A. Uterine leukocytes and decidualization. Hum. Reprod. Update, 2000; 6:28–36.
King A. E., Critchley H. O. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J. Steroid. Biochem. Mol. Biol., 2010; 120 (2–3):116–126.
Kinnunen T. I., et al. Pregnancy weight gain and breast cancer risk. BMC Women s Health 2004; 4; 7:1–10.
Klebanov P. K., Jemmot J. B. Effects of expectations and bodily sensations on self-reports of premenstrual symptoms. Psychology of Women Quarterly, 1992; 16:289–310.
Klijn J. G., Setyono-Han B., Foekens J. A. Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer. Steroids, 2000; 65:825–830.
Kline L. W., Karpinski E. Progesterone inhibits gallbladder motility through multiple signaling pathways. Steroids, 2005; 70 (9):673–679.
Knackstedt M. K., et al. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am. J. Reprod. Immunol., 2003; 49:210–220.
Knight C. Menstruation as medicine. Soc. Sci. Med., 1985; 21 (6):671–683.
Kocer A., et al. Germ cell sex determination in mammals. Mol. Human. Reprod., 2009; 15 (4):205–213.
Kol S., Humaidan P., Itskovitz-Eldor J. GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Human Reproduction, 2011; 26 (10):2874–2877.
Kolibianakis E. M., Devroey P. The luteal phase after ovarian stimulation. Reprod. Biomed. Online, 2002; 5:26–35.
Kolibianakis E. M., et al. Abnormal endometrial development occurs during the luteal phase of non supplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil. Steril., 2003; 80:464–466.
Kolpin D. W., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci. Technol., 2002; 36:1202–1211.
Komatsu T., et al. Expression of class I human leukocyte antigen (HLA) and β2-microglobulin is associated with decidualization of human endometrial stromal cells. Hum. Reprod., 1998; 13:2246–2251.
Kondo I., Suganuma N. Embryo quality in failed in vitro fertilization patients. Hum. Reprod., 1994; 4:80–84.
Konno T., et al. Subfertility Linked to Combined Luteal Insufficiency and Uterine Progesterone Resistance. Endocrinol., 2010; 151:4537–4550.
Korownyk C., Allan M., McCormack J. Bioidentical hormone micronized progesterone. Can. Fam. Physic, 2012; 58:755.
Kousta E., et al. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals. Hormones (Athens), 2010; 9 (3):218–232.
Kramer M. M., Harman M. T., Brill A. K. Disturbances of reproduction and ovarian changes in the guinea-pig in relation to vitamin C deficiency. Am. J. Physiol., 1933; 106:611–622.
Krassas G. E. Thyroid Disease and Female Reproduction. Fertil. Steril., 2000; 74:1063–1070.
Krausz C., et al. Two functional assays of sperm responsiveness to progesterone and their predictive values in in-vitro fertilization. Hum. Reprod., 1996; 11:1661–1667.
Krikun G., Schatz F., Lockwood C. J. Endometrial angiogenesis: from physiology to pathology. Ann. N. Y. Acad. Sci., 2004; 1034:27–35.
Kubasick N. K., Hallawer G. D., Brodows R. G. Evaluation of a direct solid phase radioimmunoassay for progesterone. Clin. Chem., 1984; 30:284–286.
Kugaya A., et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry, 2003; 160:1522–1524.
Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 2005; 8 (suppl 1):3–63.
Kunz G., et al. Adenomyosis as a disorder of the early and late human reproductive period. Reproductive Biomedicine Online, 2007; 15:681–685.
Kunz G., et al. Adenomyosis in endometriosis — prevalence and impact on fertility. Evidence from magnetic resonance imaging. Human Reproduc., 2005; 20:2309–2316.
Kupperman H. Progesterone and related steroids in the management of abortion. In: Barnes A., editor. Progesterone. Augusta, MI: Brook Lodge Press, 1961;105–117.
Kurita T., et al. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis. Endocrinology, 1998; 139:4708–4713.
Kurokawa J., Furukawa T. Non-genomic Action of Sex Steroid Hormones and Cardiac Repolarization. Biol. Pharm. Bull., 2013; 36 (1):8–12.
Kwak-Kim J. Y., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum. Reprod., 2003; 18:767–773.